JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B5321 DOI hydrochloride

Target: 5-HT2 Receptors

Summary: A brain-permeable 5-HT_2A/5-HT_2C receptor agonist

Soluble in H2O
B2240 Olanzapine

Target: 5-HT2 Receptors|D2 Receptors

Summary: Antagonist of 5-HT2A and dopamine D2 receptors

insoluble in H2O; ≥15.6 mg/mL
B1001 Loxapine
1 Citation

Target: 5-HT2 Receptors

Summary: 5-HT receptor antagonist

≥55.6 mg/mL
B1477 Lurasidone HCl

Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors

Summary: Dopamine D2/5-HT2A/5-HT7/5-HT1A inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.11 mg/mL
B1206 Pizotifen

Target: 5-HT2 Receptors

Summary: Highly selective 5-HT receptor blocking agent

insoluble in H2O; ≥14.77 mg/mL
B2007 Pizotifen Malate

Target: 5-HT2 Receptors|D2 Receptors

Summary: 5-HT receptor antagonist

≥21.48 mg/mL
B2231 Amitriptyline HCl

Target: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT Transporters

Summary: Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor

≥15.69 mg/mL
B2248 Ketanserin

Target: 5-HT2 Receptors

Summary: specific 5-HT2A serotonin receptor antagonist

≥39.5 mg/mL
B6574 BW 723C86 hydrochloride

Target: 5-HT2 Receptors

Summary: 5-HT2B agonist

Soluble in DMSO